Qing Kay Li, MD PhD FCAP
Qing Kay Li, MD PhD FCAP
Professor of Pathology and Oncology, the Johns Hopkins Hospitals
Verified email at
Cited by
Cited by
Direct detection of early-stage cancers using circulating tumor DNA
J Phallen, M Sausen, V Adleff, A Leal, C Hruban, J White, V Anagnostou, ...
Science translational medicine 9 (403), eaan2415, 2017
Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer.
cancer discov, 2016
Control of PD-L1 expressioon by oncogenic activation of the AKT/mTOR pathway in non-small cell lung cancer.
DPA Lastwika KJ, Wilson W 3rd, Li QK, Norris J, Xu H, Ghazarian SR, Kitagawa ...
Cancer Res 76, 227-238, 2016
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to …
L Osmani, F Askin, E Gabrielson, QK Li
Seminars in cancer biology 52, 103-109, 2018
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Cell 182 (1), 200-225, 2020
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
M Sausen, J Phallen, V Adleff, S Jones, RJ Leary, MT Barrett, ...
Nature communications 6 (1), 7686, 2015
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
CPTA Consortium.
Cell 179 (4), 964-983, 2019
The genomic landscape of response to EGFR blockade in colorectal cancer
A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ...
Nature 526 (7572), 263, 2015
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
H Miao, BR Wei, DM Peehl, Q Li, T Alexandrou, JR Schelling, JS Rhim, ...
Nature cell biology 3 (5), 527-530, 2001
Proteogenomic and metabolomic characterization of human glioblastoma.
Cancer Cell, 2021
Proteogenomic characterization of endometrial carcinoma
Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ...
Cell 180 (4), 729-748. e26, 2020
Proteogenomic characterization of pancreatic ductal adenocarcinoma
L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ...
Cell 184 (19), 5031-5052. e26, 2021
Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ...
Cancer research 79 (6), 1214-1225, 2019
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ...
Cancer cell 39 (3), 361-379. e16, 2021
A proteogenomic portrait of lung squamous cell carcinoma
S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ...
Cell 184 (16), 4348-4371. e40, 2021
Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor …
Y Liu, J Chen, A Sethi, QK Li, L Chen, B Collins, LCJ Gillet, B Wollscheid, ...
Molecular & Cellular Proteomics 13 (7), 1753-1768, 2014
Protein kinase Cδ is required for p47phox phosphorylation and translocation in activated human monocytes
EA Bey, B Xu, A Bhattacharjee, CM Oldfield, X Zhao, Q Li, ...
The Journal of Immunology 173 (9), 5730-5738, 2004
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
V Anagnostou, N Niknafs, K Marrone, DC Bruhm, JR White, J Naidoo, ...
Nature Cancer 1 (1), 99-111, 2020
INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity
LM Rooper, R Sharma, QK Li, PB Illei, WH Westra
The American Journal of Surgical Pathology 41 (11), 1561-1569, 2017
The system can't perform the operation now. Try again later.
Articles 1–20